Jin-An Jiao - 19 Jul 2021 Form 3 Insider Report for HCW Biologics Inc. (HCWB)

Role
VP of Development
Signature
/s/ Hing C. Wong, as Attorney-in-Fact for Jin-an Jiao
Issuer symbol
HCWB
Transactions as of
19 Jul 2021
Net transactions value
$0
Form type
3
Filing time
19 Jul 2021, 16:58:50 UTC
Next filing
10 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCWB Common Stock 20,571 19 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCWB Stock Option (Right to Buy) 19 Jul 2021 Common Stock 30,857 $0.1400 Direct F1
holding HCWB Stock Option (Right to Buy) 19 Jul 2021 Common Stock 8,571 $0.2100 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These option shares were part of a stock option grant covering 51,428 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant will vest on May 30, 2022; and 35% of the total shares subject to the stock option grant will vest on May 30, 2023.
F2 20% of the total shares subject to the stock option grant will vest on December 22, 2021; 20% of the total shares subject to the stock option grant will vest on December 22, 2022; 25% of the total shares subject to the stock option grant will vest on December 22, 2023; and 35% of the total shares subject to the stock option grant will vest on December 22, 2024.

Remarks:

Exhibit 24.1: Power of Attorney